The Value of Urinary Fibrin/Fibrinogen Degradation Products as Tumor Markers in Urothelial Carcinoma

Authors:

Abstract
Urinary fibrin/fibrinogen degradation products as biological tumor markers in urothelial carcinoma have been studied and compared to urinary cytology. In 93 per cent of the patients with urothelial carcinoma urinary fibrin/fibrinogen degradation product levels were elevated significantly. There was excellent correlation when the urinary cytology and urinary fibrin/fibrinogen degradation product results were compared together to cystoscopic findings.

This publication has 14 references indexed in Scilit: